HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY. Wang, Fred R. Hirsch, Robert C. Doebele et al.|Annals of Oncology|2018Cited by 217
A retrospective study on the impact of the number of resected lymph nodes on the survival outcome of stage IV rectal cancer patients after preoperative therapyKexiang Xi, Kexing Xi, Hui Yu|Journal of Gastrointestinal Oncology|2020Cited by 2